🔴 Absci is trading 10.11% down today as rising Treasury yields weigh on biotech shares

Absci is trading at $9.03, down 10.11%, amid a broad risk-off selloff.

• On October 22, Reuters cited renewed pressure on growth stocks, while Bloomberg reported that rising Treasury yields were weighing on biotech shares.
• Higher oil prices amid Middle East tensions and worries about AI spending added to market caution.
• No clear company-specific announcement explaining the drop surfaced in available coverage; Absci’s third-quarter results are scheduled for November 12.